04:03 PM EDT, 08/26/2024 (MT Newswires) -- Health care stocks eased Monday with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down 0.1%.

The iShares Biotechnology ETF (IBB) fell 0.1%.

In corporate news, Medirom Healthcare Technologies ( MRM ) shares more than doubled. The company said NFES Technologies agreed to be the lead investor in Medirom Mother Labs' series A financing round.

MoonLake Immunotherapeutics ( MLTX ) shares dropped 3.2% as Wolfe Research downgraded the stock to peer perform from outperform.

McKesson (MCK) agreed to buy a controlling stake in the business and administrative services division of Florida Cancer Specialists & Research Institute, a closely held operator of cancer clinics, for $2.49 billion in cash. McKesson shares fell 1.3%.

Rhythm Pharmaceuticals ( RYTM ) shares jumped 8.4%. The company said the US Food and Drug Administration accepted its supplemental new drug application for Imcivree to treat obesity due to Bardet-Biedl syndrome or pro-opiomelanocortin in children as young as 2 years old.